European Journal of Cancer
Volume 37, Issue 18 , Pages 2457-2463, December 2001

Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat

  • G Cavaletti

      Affiliations

    • Clinica Neurologica, A.O.S. Gerardo, Monza, Italy
    • Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano “Bicocca”, Monza, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39+233-3495; fax: +39+02+7004-38655
  • ,
  • G Tredici

      Affiliations

    • Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano “Bicocca”, Monza, Italy
  • ,
  • M.G Petruccioli

      Affiliations

    • Dipartimento di Anatomia Umana, Università di Milano, Milano, Italy
  • ,
  • E Dondè

      Affiliations

    • Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano “Bicocca”, Monza, Italy
  • ,
  • P Tredici

      Affiliations

    • Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano “Bicocca”, Monza, Italy
  • ,
  • P Marmiroli

      Affiliations

    • Dipartimento di Neuroscienze e Tecnologie Biomediche, Università di Milano “Bicocca”, Monza, Italy
  • ,
  • C Minoia

      Affiliations

    • Clinica del Lavoro, Fondazione Maugeri, Pavia, Italy
  • ,
  • A Ronchi

      Affiliations

    • Clinica del Lavoro, Fondazione Maugeri, Pavia, Italy
  • ,
  • M Bayssas

      Affiliations

    • Debiopharm S.A., Lausanne, Switzerland
  • ,
  • G Griffon Etienne

      Affiliations

    • Debiopharm S.A., Lausanne, Switzerland

Received 2 April 2001; received in revised form 5 June 2001; accepted 29 August 2001.

Abstract 

The aim of this study was to determine the influence of oxaliplatin scheduling on the onset of peripheral neurotoxicity and ototoxicity in a rat model. Animals were treated with four different schedules of oxaliplatin using two cumulative doses (36 and 48 mg/kg intraperitoneally (i.p.)). The neuropathological examination evidenced dorsal root ganglia (DRG) nucleolar, nuclear and somatic size reduction with nucleolar segregation in the treated rats. Sensory nerve conduction velocity (SNCV) was reduced after oxaliplatin treatment, while the auditory pathway was unaffected. After treatment, platinum was detected in the kidney, DRG and sciatic nerve. After a 5-week follow-up period, recovery of the pathological changes in the DRG and sciatic nerves occurred, although platinum was still detectable in these tissues. The following conclusions may be drawn: the main targets of oxaliplatin neurotoxicity were the DRG; the shorter the interval between the injections, the higher the severity of peripheral neuropathy and this was also related to the cumulative oxaliplatin dose; the peripheral neurotoxicity tended to be reversible; ototoxicity was absent even with high cumulative doses of oxaliplatin.

Keywords:  Audiometry, Neuropathy, Oxaliplatin, Rat, Toxicity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(01)00300-8

doi:10.1016/S0959-8049(01)00300-8

European Journal of Cancer
Volume 37, Issue 18 , Pages 2457-2463, December 2001